<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01391676</url>
  </required_header>
  <id_info>
    <org_study_id>SD OCT-TE</org_study_id>
    <nct_id>NCT01391676</nct_id>
  </id_info>
  <brief_title>Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography</brief_title>
  <acronym>SDOCT-TE</acronym>
  <official_title>Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is imaging of trabeculectomy blebs regarding structure and function
      with the spectral domain optical coherence tomography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After a trabeculectomy with mitomycin C 0,02% for 3 minutes, the blebs are controlled by a
      glaucoma specialist on day 1, week 1,2,3,4, month 3 and 6 after surgery. The glaucoma
      specialist will evaluate the bleb appearance according to a standardized protocol. At the
      same time points the bleb will be imaged with the spectral domain optical coherence
      tomography, to monitor bleb changes objectively. The investigators hope to see signs of bleb
      incapsulation and scarring earlier and then treat the patient accordingly.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>grading of filtering bleb</measure>
    <time_frame>December 2011</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Glaucoma</condition>
  <condition>Filtering Blebs</condition>
  <arm_group>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <description>glaucoma patients undergoing trabeculectomy with mitomycin c 0,02%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trabeculectomy</intervention_name>
    <description>postoperative imaging of trabeculectomy blebs with the spectral domain optical coherence tomography</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        glaucoma patients who need a trabeculectomy with mitomycin C 0,02% for further reduction of
        intraocular pressure (IOP)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        glaucoma patients who need a trabeculectomy with mitomycin C 0,02% for further reduction of
        intraocular pressure, informed consent

        Exclusion Criteria:

        patient without glaucoma, under 18 years of age, not willing to take part in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin R Hornykewycz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Eye Clinic Dresden, Fetscherstrasse 74, 01307 Dresden, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Eye Clinic Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2011</study_first_submitted>
  <study_first_submitted_qc>July 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2011</study_first_posted>
  <last_update_submitted>September 9, 2013</last_update_submitted>
  <last_update_submitted_qc>September 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität Dresden</investigator_affiliation>
    <investigator_full_name>Dr. Karin Pillunat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>trabeculectomy</keyword>
  <keyword>filtering bleb</keyword>
  <keyword>spectral domain optical coherence tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

